Theralase Technologies Inc.
TLT.V
TSX
Weiss Ratings | TLT.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Very Weak | |||
Risk Index | Weak | |||
Risk Grade | D- | |||
Reward Grade | E | |||
Rating Factors | TLT.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Fair | |||
Efficiency Index | Very Weak | |||
Solvency Index | Good | |||
Total Return Index | Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | TLT.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.51 | |||
Price History | TLT.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 27.50% | |||
30-Day Total Return | -8.93% | |||
60-Day Total Return | -16.39% | |||
90-Day Total Return | -13.56% | |||
Year to Date Total Return | -7.27% | |||
1-Year Total Return | 59.38% | |||
2-Year Total Return | -5.56% | |||
3-Year Total Return | -44.57% | |||
5-Year Total Return | 34.21% | |||
52-Week High % Change | -53.95% | |||
52-Week Low % Change | 25.00% | |||
Price | TLT.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $0.38 | |||
52-Week Low Price | $0.14 | |||
52-Week Low Price (Date) | May 30, 2024 | |||
52-Week High Price (Date) | Oct 21, 2024 | |||
Valuation | TLT.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 30.29M | |||
Enterprise Value | 30.31M | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -0.01 | |||
Earnings Per Share Growth | -14.84% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 60.34 | |||
Price/Book (Q) | 30.17 | |||
Enterprise Value/Revenue (TTM) | 40.35 | |||
Price | $0.26 | |||
Enterprise Value/EBITDA (TTM) | -10.09 | |||
Enterprise Value/EBIT | -9.67 | |||
Market Cap Category | Nano Cap | |||
Dividends and Shares | TLT.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 256.41M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | TLT.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 416 699 5273 | |||
Address | 41 Hollinger Road Toronto, ON M4B 3G4 | |||
Website | www.theralase.com | |||
Country | Canada | |||
Year Founded | -- | |||
Profitability | TLT.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -417.30% | |||
Profit Margin | -414.17% | |||
Management Effectiveness | TLT.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -82.71% | |||
Return on Equity | -- | |||
Income Statement | TLT.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 751.20K | |||
Total Revenue (TTM) | 751.20K | |||
Revenue Per Share | $0.00 | |||
Gross Profit (TTM) | 401.70K | |||
EBITDA (TTM) | -3.01M | |||
EBIT (TTM) | -3.13M | |||
Net Income (TTM) | -3.11M | |||
Net Income Avl. to Common (TTM) | -3.11M | |||
Total Revenue Growth (Q YOY) | 9.69% | |||
Earnings Growth (Q YOY) | 9.95% | |||
EPS Diluted (TTM) | -0.01 | |||
EPS Diluted Growth (Q YOY) | 18.75% | |||
Balance Sheet | TLT.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 186.80K | |||
Cash Per Share (Q) | $0.00 | |||
Total Current Assets (Q) | 1.10M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 1.44M | |||
Current Ratio (Q) | 1.606 | |||
Book Value Per Share (Q) | $0.01 | |||
Total Assets (Q) | 2.26M | |||
Total Current Liabilities (Q) | 685.20K | |||
Total Debt (Q) | 204.20K | |||
Total Liabilities (Q) | 819.80K | |||
Total Common Equity (Q) | 1.44M | |||
Cash Flow | TLT.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -14.50K | |||
Cash from Financing (TTM) | 2.62M | |||
Net Change in Cash (TTM) | 165.80K | |||
Levered Free Cash Flow (TTM) | -1.52M | |||
Cash from Operations (TTM) | -2.44M | |||